JPS58134017A - 経鼻用医薬組成物 - Google Patents

経鼻用医薬組成物

Info

Publication number
JPS58134017A
JPS58134017A JP58015392A JP1539283A JPS58134017A JP S58134017 A JPS58134017 A JP S58134017A JP 58015392 A JP58015392 A JP 58015392A JP 1539283 A JP1539283 A JP 1539283A JP S58134017 A JPS58134017 A JP S58134017A
Authority
JP
Japan
Prior art keywords
composition according
item
composition
items
active ingredient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP58015392A
Other languages
English (en)
Japanese (ja)
Other versions
JPH0253406B2 (sv
Inventor
ジヤン−ルネ・キシエル
フランソワ−ズ・アセザ−ミスペルテ
ダニエル・プラ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of JPS58134017A publication Critical patent/JPS58134017A/ja
Publication of JPH0253406B2 publication Critical patent/JPH0253406B2/ja
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Otolaryngology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
JP58015392A 1982-02-01 1983-01-31 経鼻用医薬組成物 Granted JPS58134017A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8202781 1982-02-01
GB8202781 1982-02-01

Publications (2)

Publication Number Publication Date
JPS58134017A true JPS58134017A (ja) 1983-08-10
JPH0253406B2 JPH0253406B2 (sv) 1990-11-16

Family

ID=10528017

Family Applications (1)

Application Number Title Priority Date Filing Date
JP58015392A Granted JPS58134017A (ja) 1982-02-01 1983-01-31 経鼻用医薬組成物

Country Status (27)

Country Link
JP (1) JPS58134017A (sv)
AT (1) AT385656B (sv)
AU (1) AU565613B2 (sv)
BE (1) BE895750A (sv)
CA (1) CA1197783A (sv)
CH (1) CH653555A5 (sv)
DE (1) DE3302949A1 (sv)
DK (1) DK164771C (sv)
ES (1) ES519450A0 (sv)
FI (1) FI81258C (sv)
FR (1) FR2539994B1 (sv)
GR (1) GR81320B (sv)
HK (1) HK59989A (sv)
HU (1) HU191512B (sv)
IE (1) IE54532B1 (sv)
IL (1) IL67822A (sv)
IT (1) IT1197558B (sv)
KE (1) KE3888A (sv)
LU (1) LU84613A1 (sv)
MY (1) MY8700766A (sv)
NL (1) NL192325C (sv)
NZ (1) NZ203117A (sv)
PH (1) PH22198A (sv)
PT (1) PT76166B (sv)
SE (1) SE454402B (sv)
SG (1) SG34389G (sv)
ZA (1) ZA83673B (sv)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012530121A (ja) * 2009-06-16 2012-11-29 バイオコピア リミテッド 咳の治療のためのテオブロミン
JP2021510155A (ja) * 2018-01-05 2021-04-15 インペル ニューロファーマ インコーポレイテッド 精密嗅覚デバイスによるジヒドロエルゴタミンの鼻腔内送達

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0715285D0 (en) * 2007-08-06 2007-09-12 Britannia Pharmaceuticals Ltd Improvements in or relating to powdered medicaments for nasal delivery

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3091569A (en) * 1960-08-26 1963-05-28 Mead Johnson & Co Mucolytic-nu-acylated sulfhydryl compositions and process for treating animal mucus
GB1202885A (en) * 1966-12-22 1970-08-19 Sandoz Ltd Pharmaceutical compositions comprising alkaloids
DE2750090A1 (de) * 1976-11-19 1978-06-01 Sandoz Ag Neue verabreichungsformen fuer organische verbindungen
FR2387035A1 (fr) * 1977-04-12 1978-11-10 Cassenne Lab Sa Nouveau medicament destine notamment au traitement des troubles fonctionnels cerebraux
DE2831728C2 (de) * 1978-07-19 1982-12-23 Krewel-Werke Gmbh, 5208 Eitorf Arzneimittel zur Behandlung von Kopfschmerzen

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012530121A (ja) * 2009-06-16 2012-11-29 バイオコピア リミテッド 咳の治療のためのテオブロミン
JP2021510155A (ja) * 2018-01-05 2021-04-15 インペル ニューロファーマ インコーポレイテッド 精密嗅覚デバイスによるジヒドロエルゴタミンの鼻腔内送達

Also Published As

Publication number Publication date
IT8347646A0 (it) 1983-02-01
IL67822A (en) 1988-02-29
JPH0253406B2 (sv) 1990-11-16
AU565613B2 (en) 1987-09-24
ES8502865A1 (es) 1985-02-01
KE3888A (en) 1989-09-01
IT1197558B (it) 1988-12-06
FR2539994B1 (fr) 1986-10-10
NL192325B (nl) 1997-02-03
DK164771B (da) 1992-08-17
CA1197783A (en) 1985-12-10
FI830245A0 (fi) 1983-01-25
IE830187L (en) 1983-08-01
DE3302949A1 (de) 1983-08-11
BE895750A (fr) 1983-08-01
PH22198A (en) 1988-06-28
AU1085083A (en) 1983-08-11
ATA30383A (de) 1987-10-15
SG34389G (en) 1989-09-22
MY8700766A (en) 1987-12-31
SE454402B (sv) 1988-05-02
DK164771C (da) 1992-12-28
PT76166A (en) 1983-02-01
FI81258B (fi) 1990-06-29
NZ203117A (en) 1986-12-05
NL8300325A (nl) 1983-09-01
LU84613A1 (fr) 1983-09-08
DK38183D0 (da) 1983-01-31
CH653555A5 (de) 1986-01-15
DE3302949C2 (sv) 1992-05-21
AT385656B (de) 1988-05-10
NL192325C (nl) 1997-06-04
DK38183A (da) 1983-08-02
SE8300495L (sv) 1983-08-02
FR2539994A1 (fr) 1984-08-03
SE8300495D0 (sv) 1983-01-31
ZA83673B (en) 1984-09-26
GR81320B (sv) 1984-12-11
FI81258C (sv) 1990-10-10
IE54532B1 (en) 1989-11-08
PT76166B (en) 1986-02-04
HU191512B (en) 1987-02-27
FI830245L (fi) 1983-08-02
HK59989A (en) 1989-08-04
ES519450A0 (es) 1985-02-01
IL67822A0 (en) 1983-06-15

Similar Documents

Publication Publication Date Title
US11717571B2 (en) Intranasal epinephrine formulations and methods for the treatment of disease
AU714303B2 (en) Formulation for intranasal administration
US5169849A (en) Nasal pharmaceutical compositions
EP1227812B1 (en) Topical nasal treatment using desloratadine and mometasone furoate
RU2767062C2 (ru) Составы, устройства и способы для лечения алкогольной зависимости
CN115397417A (zh) 含有噻托溴铵和奥达特罗的可吸入溶液制剂
JP2001518923A (ja) 鼻腔用メラトニン組成物
AU2024201523A1 (en) Intranasal epinephrine formulations and methods for the treatment of disease
US20200390691A1 (en) Compositions, devices, and methods for the treatment of overdose and reward-based disorders
WO1996000071A1 (en) Treatment of nicotine craving and/or smoking withdrawal symptoms with a liquid nasal composition containing nicotine and caffeine or xanthine
JPS58134017A (ja) 経鼻用医薬組成物
GB2114001A (en) Nasal pharmaceutical compositions
WO1996000069A1 (en) Treatment of nicotine craving and/or smoking withdrawal symptoms with a solid or semi-solid composition containing nicotine and caffeine or xanthine, especially for nasal administration
KR20210131996A (ko) 과다복용 및 보상-기반 장애의 치료를 위한 조성물, 장치 및 방법
ES2398576T3 (es) Tratamiento agudo de la fobia social con un esteroide androsta-4,16-dien-3-ol
JP2002370977A (ja) 局所適用組成物